If you are going to play in the RNN game then you need to have a two year horizon for the big money. Remember DNDN. It went from 4 to 50 in a several months after a couple year wait. No guts No glory.
ISIS is another good lesson in patience. Not enough of this these days, IMHO. Longs, enjoy your weekend.
Next week is setting up to be a good one - but the real glory may be months or years down the road. Stay long and thirsty my friends. As for the shorts and bashers - never mind. Try to sleep well, eh? Three weeks until the rent is due....
This is a lotto stock. Having said that it is a lotto I want to play. The three CA's that have shown no improvement in survival over the last twenty years are Lung CA, esophageal CA, and pancreatic CA. If their AKt1 inhibitor holds for improvement in pancreatic CA in humans like it has shown in animals studies this stock could easily go to $40 a share. Not an easy task, you just have to look at GNVC to see what can happen. However, I believe it will be successful and will continue to load up on this stock. The potential is huge, even beyond the pancreatic CA use for Archexin. I am going to try and call their IR next week and will report what info I get. ISIS is the leader in ANS technology. I would like to know the drug discovery process that RNN is using in regards to their ANS drugs. ISIS has an extremely prolific drug discovery process. They will be able to come up with three to five new drug candidates per year. If the RNN drug discovery process for ANS drugs is one-fifth that it would still be tremendous. I'm going to post any AKt1 inhibition in CA that I can find in the CA literature. t
You're sure? Were it THAT easy, it wouldn't sell for $1 in my experience.Spare me the examples of stocks that WERE $1 and then shot up because I can produce a list of delisted $1 "WINNERS".Nonetheless, I'm long and strong..I object to overly exuberant GUESSES which are just THAT.
Sentiment: Strong Buy